Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/134306COMPARTIR / EXPORTAR:
 SHARE
 CORE
BASE
|
|
| Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
| Título: | The proliferation index of specific bone marrow cell compartments from myelodysplastic syndromes is associated with the diagnostic and patient outcome |
Autor: | Matarraz, Sergio; Teodosio, Cristina; Fernández, Carlos CSIC; Jara-Acevedo, Maria; López, Antonio; González González, María; Gutiérrez, María Laura; Flores-Montero, Juan; Orfao, Alberto CSIC ORCID | Fecha de publicación: | 2012 | Editor: | Public Library of Science | Citación: | PLoS ONE 7(8): e44321 (2012) | Resumen: | Myelodysplastic syndromes (MDS) are clonal stem cell disorders which frequently show a hypercellular dysplastic bone marrow (BM) associated with inefficient hematopoiesis and peripheral cytopenias due to increased apoptosis and maturation blockades. Currently, little is known about the role of cell proliferation in compensating for the BM failure syndrome and in determining patient outcome. Here, we analyzed the proliferation index (PI) of different compartments of BM hematopoietic cells in 106 MDS patients compared to both normal/reactive BM (n = 94) and acute myeloid leukemia (AML; n = 30 cases) using multiparameter flow cytometry. Our results show abnormally increased overall BM proliferation profiles in MDS which significantly differ between early/low-risk and advanced/high-risk cases. Early/low-risk patients showed increased proliferation of non-lymphoid CD34 + precursors, maturing neutrophils and nucleated red blood cells (NRBC), while the PI of these compartments of BM precursors progressively fell below normal values towards AML levels in advanced/high-risk MDS. Decreased proliferation of non-lymphoid CD34 + and NRBC precursors was significantly associated with adverse disease features, shorter overall survival (OS) and transformation to AML, both in the whole series and when low- and high-risk MDS patients were separately considered, the PI of NRBC emerging as the most powerful independent predictor for OS and progression to AML. In conclusion, assessment of the PI of NRBC, and potentially also of other compartments of BM precursors (e.g.: myeloid CD34 + HPC), could significantly contribute to a better management of MDS. | Descripción: | This is an open-access article distributed under the terms of the Creative Commons Attribution License.-- et al. | Versión del editor: | http://dx.doi.org/10.1371/journal.pone.0044321 | URI: | http://hdl.handle.net/10261/134306 | DOI: | 10.1371/journal.pone.0044321 | Identificadores: | doi: 10.1371/journal.pone.0044321 issn: 1932-6203 |
| Aparece en las colecciones: | (IBMCC) Artículos |
Ficheros en este ítem:
| Fichero | Descripción | Tamaño | Formato | |
|---|---|---|---|---|
| Bone Marrow Cell.PDF | 532,34 kB | Adobe PDF |  Visualizar/Abrir |
CORE Recommender
PubMed Central
Citations
9
checked on 19-mar-2024
SCOPUSTM
Citations
13
checked on 17-abr-2024
WEB OF SCIENCETM
Citations
13
checked on 23-feb-2024
Page view(s)
243
checked on 24-abr-2024
Download(s)
254
checked on 24-abr-2024
